X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (37) 37
male (36) 36
female (30) 30
middle aged (27) 27
adult (24) 24
aged (22) 22
index medicus (21) 21
lung neoplasms - drug therapy (14) 14
oncology (14) 14
treatment outcome (14) 14
carcinoma, non-small-cell lung - drug therapy (12) 12
lung cancer (12) 12
respiratory system (12) 12
chemotherapy (10) 10
lung neoplasms - pathology (10) 10
survival (10) 10
carcinoma, non-small-cell lung - pathology (9) 9
lung neoplasms - mortality (9) 9
aged, 80 and over (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
carcinoma, non-small-cell lung - mortality (8) 8
cisplatin - administration & dosage (7) 7
hematology, oncology and palliative medicine (7) 7
lung cancer, non-small cell (7) 7
prognosis (7) 7
retrospective studies (7) 7
survival analysis (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
carboplatin (6) 6
deoxycytidine - analogs & derivatives (6) 6
paclitaxel (6) 6
prospective studies (6) 6
pulmonary/respiratory (6) 6
quality of life (6) 6
smoking (6) 6
turkey (6) 6
bronchoscopy (5) 5
cancer (5) 5
cisplatin (5) 5
deoxycytidine - administration & dosage (5) 5
deoxycytidine - adverse effects (5) 5
gemcitabine (5) 5
non-small cell lung cancer (5) 5
surgery (5) 5
survival rate (5) 5
turkey - epidemiology (5) 5
antineoplastic combined chemotherapy protocols - administration & dosage (4) 4
bevacizumab (4) 4
cisplatin - adverse effects (4) 4
diagnosis (4) 4
follow-up (4) 4
kaplan-meier estimate (4) 4
medicine & public health (4) 4
neoplasm staging (4) 4
quality-of-life (4) 4
research (4) 4
risk assessment (4) 4
1st-line treatment (3) 3
adolescent (3) 3
analysis (3) 3
antioxidants (3) 3
carcinoma, non-small-cell lung (3) 3
cardiac & cardiovascular systems (3) 3
care and treatment (3) 3
clinical trials (3) 3
combination (3) 3
double-blind method (3) 3
education (3) 3
erlotinib (3) 3
etoposide - administration & dosage (3) 3
expression (3) 3
follow-up studies (3) 3
glutamates - administration & dosage (3) 3
glutamates - adverse effects (3) 3
guanine - administration & dosage (3) 3
guanine - adverse effects (3) 3
guanine - analogs & derivatives (3) 3
histology (3) 3
lung neoplasms - epidemiology (3) 3
medical prognosis (3) 3
neoplasm metastasis (3) 3
orthopedics (3) 3
patients (3) 3
pemetrexed (3) 3
pharmacology & pharmacy (3) 3
prevalence (3) 3
radiology, nuclear medicine & medical imaging (3) 3
respiratory tract diseases (3) 3
rheumatology (3) 3
sensitivity and specificity (3) 3
taxoids - administration & dosage (3) 3
abridged index medicus (2) 2
adenocarcinoma - epidemiology (2) 2
adenocarcinoma - pathology (2) 2
angiogenesis (2) 2
animals (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - therapeutic use (2) 2
anxiety (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9944, pp. 665 - 673
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2008, Volume 26, Issue 21, pp. 3543 - 3551
Journal Article
Cancer Epidemiology, ISSN 1877-7821, 2015, Volume 39, Issue 2, pp. 216 - 221
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2012, Volume 30, Issue 29, pp. 3640 - 3647
Journal Article
by Mok, Tony and Mok, Tony S K and Wu, Yilong and Wu, Yi-Long and Kudaba, Iveta and Kowalski, Dariusz M and Kowalski, Dariusz and Cho, Byoung Chul and Turna, Hande and Turna, Hande Z and Castro, Hugo and Castro, Gilberto and Srimuninnimit, Vichien and Laktionov, Konstantin and Laktionov, Konstantin K and Bondarenko, Igor and Kubota, Kaoru and Lubiniecki, Gregory M and Zhang, Jin and Zhang, Li and Zhang, Xin and Kush, Debra and Lopes, Valeria and Lopes, Gilberto and Adamchuk, Grigory and Ahn, Myung-Ju and Alexandru, Aurelia and Altundag, Ozden and Alyasova, Anna and Andrusenko, Orest and Aoe, Keisuke and Araujo, Antonio and Aren, Osvaldo and Arrieta Rodriguez, Oscar and Ativitavas, Touch and Avendano, Oscar and Barata, Fernando and Barrios, Carlos Henrique and Beato, Carlos and Bergstrom, Per and Betticher, Daniel and Bolotina, Larisa and Botha, Michiel and Buddu, Sayeuri and Caglevic, Christian and Cardona, Andres and Cay Senler, Filiz and Cerny, Carlos Alexandre Sydow and Cesas, Alvydas and Chan, Gee-Chen and Chang, Jianhua and Chen, Xi and Chen, Gongyan and Cheng, Ying and Cheng, Susanna and Cherciu, Nelly and Chiu, Chao-Hua and Cicenas, Saulius and Ciurescu, Daniel and Cohen, Graham and Costa, Marcos Andre and Danchaivijitr, Pongwut and De Angelis, Flavia and de Azevedo, Sergio Jobim and Dediu, Mircea and Deliverski, Tsvetan and De Marchi, Pedro Rafael Martins and de The Bustamante Valles, Flor and Ding, Zhenyu and Doganov, Boyan and Dreosti, Lydia and Duarte, Ricardo and Edusma-Dy, Regina and Emelyanov, Sergey and Erman, Mustafa and Fan, Yun and Fein, Luis and Feng, Jifeng and Fenton, David and Fernandes, Gustavo and Ferreira, Carlos and Franke, Fabio Andre and Freitas, Helano and Fujisaka, Yasuhito and Galindo, Hector and Galvez, Christina and Ganea, Doina and Gil, Nuno and Girotto, Gustavo and Goker, Erdem and Goksel, Tuncay and Gomez Aubin, Gonzalo and Gomez Wolff, Luis and Griph, Hakan and Gumus, Mahmut and Hall, Jacqueline and Hart, Gregory and Havel, Libor and He, Yong and He, Jianxing and ... and KEYNOTE-042 Investigators
The Lancet, ISSN 0140-6736, 05/2019, Volume 393, Issue 10183, pp. 1819 - 1830
First-line pembrolizumab monotherapy improves overall and progression-free survival in patients with untreated metastatic non-small-cell lung cancer with a... 
MEDICINE, GENERAL & INTERNAL | CARBOPLATIN | GEFITINIB | BEVACIZUMAB | CRIZOTINIB | NIVOLUMAB | PACLITAXEL | Genes, erbB-1 - drug effects | Lung Neoplasms - drug therapy | Translocation, Genetic | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Lung Neoplasms - metabolism | Middle Aged | Far East - epidemiology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Anaplastic Lymphoma Kinase - genetics | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Lung Neoplasms - secondary | Female | Carcinoma, Non-Small-Cell Lung - pathology | Anaplastic Lymphoma Kinase - drug effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Genes, erbB-1 - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Disease-Free Survival | B7-H1 Antigen - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasm Metastasis - pathology | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Chemotherapy | Metastasis | Lung cancer, Non-small cell | Cancer | Slopes | Lung cancer | Oncology | Kinases | Cancer therapies | Metastases | Pembrolizumab | Randomization | Motivation | Platinum | Risk assessment | Population | Translocation | Cell survival | Life expectancy | Epidermal growth factor receptors | Hyperthyroidism | Histology | Hypothyroidism | Survival | Patients | Medical centres | Life span | Interactive systems | PD-L1 protein | Men | Ligands | Tumors | Apoptosis
Journal Article
by Rich, Anna and Rich, Anna and Baldwin, David and Baldwin, David and Alfageme, Inmaculada and Alfageme, Inmaculada and Beckett, Paul and Beckett, Paul and Berghmans, Thierry and Berghmans, Thierry and Brincat, Stephen and Brincat, Stephen and Burghuber, Otto and Burghuber, Otto and Corlateanu, Alexandru and Corlateanu, Alexandru and Cufer, Tanja and Cufer, Tanja and Damhuis, Ronald and Damhuis, Ronald and Danila, Edvardas and Danila, Edvardas and Domagala-Kulawik, Joanna and Domagala-Kulawik, Joanna and Elia, Stefano and Elia, Stefano and Gaga, Mina and Gaga, Mina and Goksel, Tuncay and Goksel, Tuncay and Grigoriu, Bogdan and Grigoriu, Bogdan and Hillerdal, Gunnar and Hillerdal, Gunnar and Huber, Rudolf Maria and Huber, Rudolf Maria and Jakobsen, Erik and Jakobsen, Erik and Jonsson, Steinn and Jonsson, Steinn and Jovanovic, Dragana and Jovanovic, Dragana and Kavcova, Elena and Kavcova, Elena and Konsoulova, Assia and Konsoulova, Assia and Laisaar, Tanel and Laisaar, Tanel and Makitaro, Riitta and Makitaro, Riitta and Mehic, Bakir and Mehic, Bakir and Milroy, Robert and Milroy, Robert and Moldvay, Judit and Moldvay, Judit and Morgan, Ross and Morgan, Ross and Nanushi, Milda and Nanushi, Milda and Paesmans, Marianne and Paesmans, Marianne and Putora, Paul Martin and Putora, Paul Martin and Samarzija, Miroslav and Samarzija, Miroslav and Scherpereel, Arnaud and Scherpereel, Arnaud and Schlesser, Marc and Schlesser, Marc and Sculier, Jean-Paul and Sculier, Jean-Paul and Skrickova, Jana and Skrickova, Jana and Sotto-Mayor, Renato and Sotto-Mayor, Renato and Strand, Trond-Eirik and Strand, Trond-Eirik and Van Schil, Paul and Van Schil, Paul and Blum, Torsten-Gerriet and Blum, Torsten-Gerriet
BMC Cancer, ISSN 1471-2407, 11/2018, Volume 18, Issue 1, pp. 1144 - 12
Journal Article
Journal Article
Clinical and Experimental Hypertension, ISSN 1064-1963, 2019, pp. 1 - 4
: YKL-40 (human cartilage glycoprotein 39, chitinase-3-like protein 1) is an inflammatory marker secreted mainly by macrophages and has distinctive roles on... 
hypertension | major cardiovascular events | Serum YKL-40
Journal Article
Rheumatology International, ISSN 0172-8172, 1/2012, Volume 32, Issue 1, pp. 169 - 176
Journal Article
European Journal of Pharmaceutics and Biopharmaceutics, ISSN 0939-6411, 10/2017, Volume 119, pp. 17 - 27
An alternative formulation for the treatment of diabetic foot wounds that heal slowly is a requirement in pharmaceutical field. The aim of this study was to... 
Dermal matrix | Laminin | Wound healing | Collagen | Microparticles | Resveratrol | CELLS | OXIDATIVE STRESS | NANOFIBERS | REGENERATION | MEMBRANE | CROSS-LINKING |